Position statement: The need for EU legislation to require disclosure and labelling of the composition of medical devices

BACKGROUND: In recent years, skin reactions secondary to the use of medical devices (MD), such as allergic contact dermatitis have increasingly been observed (e.g. to continuous blood sugar monitoring systems, insulin pumps, wound dressings, medical gloves, etc.): this is regarded as a developing ep...

Descripción completa

Detalles Bibliográficos
Autores principales: Herman, A., Uter, W., Rustemeyer, T., Matura, M., Aalto‐Korte, K., Duus Johansen, J., Gonçalo, M., White, I.R., Balato, A., Giménez Arnau, A.M., Brockow, K., Mortz, C.G., Mahler, V., Goossens, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Guidelines and Position Statements
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251888/
https://www.ncbi.nlm.nih.gov/pubmed/33955077
http://dx.doi.org/10.1111/jdv.17238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251888/
https://www.ncbi.nlm.nih.gov/pubmed/33955077
http://dx.doi.org/10.1111/jdv.17238

Ejemplares similares